Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM50224883 (7-chloro-3-oxo-8-[(thiazol-5-ylmethyl)-amino]-11,1...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 5.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories Curated by ChEMBL | Assay Description Inhibition of PBK | Bioorg Med Chem Lett 17: 6593-601 (2007) Article DOI: 10.1016/j.bmcl.2007.09.063 BindingDB Entry DOI: 10.7270/Q2X067WT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM148993 (US8962648, 72 | US8962648, 73) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.380 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149054 (US8962648, 319) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.430 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM50520955 (CHEMBL4445123) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 0.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Sichuan University Curated by ChEMBL | Assay Description Inhibition of human TOPK using MBP as substrate after 2 hrs in presence of [gamma-33P]-ATP by filter-binding method | Eur J Med Chem 162: 407-422 (2019) Article DOI: 10.1016/j.ejmech.2018.11.007 BindingDB Entry DOI: 10.7270/Q28K7DGV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149042 (US8962648, 276) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.5 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149041 (US8962648, 275) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.540 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149027 (US8962648, 235) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.570 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM148993 (US8962648, 72 | US8962648, 73) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.630 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149118 (US8962648, 1160) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.640 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149043 (US8962648, 277) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.670 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149016 (US8962648, 195) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.730 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149039 (US8962648, 273) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.740 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149192 (US8962648, 1309) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.740 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM148997 (US8962648, 84) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.780 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149034 (US8962648, 266) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.780 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149026 (US8962648, 233) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.810 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149062 (US8962648, 336) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.820 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149097 (US8962648, 1120) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.880 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149038 (US8962648, 272) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.880 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149010 (US8962648, 187) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.900 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149074 (US8962648, 359) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.920 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149044 (US8962648, 278) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.970 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149169 (US8962648, 1271) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149087 (US8962648, 1082) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149007 (US8962648, 175 | US8962648, 176) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149007 (US8962648, 175 | US8962648, 176) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149067 (US8962648, 345) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149094 (US8962648, 1111) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149104 (US8962648, 1131) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149091 (US8962648, 1095) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149112 (US8962648, 1148) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149081 (US8962648, 1052) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149121 (US8962648, 1163) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149131 (US8962648, 1187) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149102 (US8962648, 1127) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149159 (US8962648, 1252) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149127 (US8962648, 1174) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149012 (US8962648, 191 | US8962648, 192) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.60 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM50520970 (CHEMBL4452726) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 1.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Sichuan University Curated by ChEMBL | Assay Description Inhibition of human TOPK using MBP as substrate after 2 hrs in presence of [gamma-33P]-ATP by filter-binding method | Eur J Med Chem 162: 407-422 (2019) Article DOI: 10.1016/j.ejmech.2018.11.007 BindingDB Entry DOI: 10.7270/Q28K7DGV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149185 (US8962648, 1300) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149140 (US8962648, 1209) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.80 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM148992 (US8962648, 65) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.80 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149071 (US8962648, 349) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149070 (US8962648, 348) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149065 (US8962648, 339) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149056 (US8962648, 327) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149012 (US8962648, 191 | US8962648, 192) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149072 (US8962648, 353) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149119 (US8962648, 1161) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Lymphokine-activated killer T-cell-originated protein kinase (Homo sapiens (Human)) | BDBM149052 (US8962648, 313) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | 7.4 | 25 |
OncoTherapy Science, Inc. US Patent | Assay Description PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s... | US Patent US8962648 (2015) BindingDB Entry DOI: 10.7270/Q27H1H9K | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 279 total ) | Next | Last >> |